Your browser doesn't support javascript.
loading
Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.
Eckstein, Olive S; Visser, Johannes; Rodriguez-Galindo, Carlos; Allen, Carl E.
Afiliação
  • Eckstein OS; Texas Children's Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX.
  • Visser J; Division of Pediatric Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Rodriguez-Galindo C; Department of Paediatric Haematology and Oncology, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge, United Kingdom; and.
  • Allen CE; Department of Oncology and.
Blood ; 133(15): 1691-1694, 2019 04 11.
Article em En | MEDLINE | ID: mdl-30718231
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans / Proteínas Proto-Oncogênicas B-raf Limite: Child / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans / Proteínas Proto-Oncogênicas B-raf Limite: Child / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article